Eli Lilly and Company (LLY)
 NYSE: LLY · Real-Time Price · USD
 844.50
 +30.97 (3.81%)
  At close: Oct 30, 2025, 4:00 PM EDT
844.47
 -0.03 (0.00%)
  Pre-market: Oct 31, 2025, 5:07 AM EDT
Eli Lilly Market Cap
Eli Lilly has a market cap or net worth of $756.15 billion as of October 30, 2025. Its market cap has decreased by -14.41% in one year.
Market Cap 
 756.15B
Enterprise Value 
 792.17B
1-Year Change 
 -14.41%
Ranking 
 Category 
 Stock Price 
$844.50
Market Cap Chart
Since December 1, 1998, Eli Lilly's market cap has increased from $99.25B to $756.15B, an increase of 661.88%. That is a compound annual growth rate of 7.83%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 769.97B | 5.06% | 
| Dec 31, 2024 | 732.87B | 32.44% | 
| Dec 29, 2023 | 553.37B | 59.19% | 
| Dec 30, 2022 | 347.61B | 31.56% | 
| Dec 31, 2021 | 264.23B | 63.60% | 
| Dec 31, 2020 | 161.51B | 27.99% | 
| Dec 31, 2019 | 126.19B | 2.94% | 
| Dec 31, 2018 | 122.58B | 31.81% | 
| Dec 29, 2017 | 93.00B | 14.54% | 
| Dec 30, 2016 | 81.20B | -13.04% | 
| Dec 31, 2015 | 93.37B | 21.55% | 
| Dec 31, 2014 | 76.82B | 33.69% | 
| Dec 31, 2013 | 57.46B | 0.39% | 
| Dec 31, 2012 | 57.23B | 18.95% | 
| Dec 30, 2011 | 48.12B | 19.08% | 
| Dec 31, 2010 | 40.41B | -1.52% | 
| Dec 31, 2009 | 41.03B | -10.38% | 
| Dec 31, 2008 | 45.79B | -24.40% | 
| Dec 31, 2007 | 60.56B | 2.72% | 
| Dec 29, 2006 | 58.96B | -8.34% | 
| Dec 30, 2005 | 64.32B | 0.16% | 
| Dec 31, 2004 | 64.22B | -18.68% | 
| Dec 31, 2003 | 78.97B | 10.71% | 
| Dec 31, 2002 | 71.33B | -19.21% | 
| Dec 31, 2001 | 88.30B | -15.83% | 
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Johnson & Johnson | 449.57B | 
| AbbVie | 397.72B | 
| UnitedHealth Group | 321.75B | 
| AstraZeneca | 257.84B | 
| Novartis AG | 237.42B | 
| Novo Nordisk | 232.34B | 
| Abbott Laboratories | 216.57B | 
| Merck & Co. | 216.26B |